PTC Therapeutics, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2023-05-08: Federal exemption Rule 506(b); Types of securities offered Equity; Common Stock; Date of first sale 2023-04-10; Total offering amount $35,897,425.
- 2013-02-12: Federal exemption Rule 506; Types of securities offered Debt; OptionToAcquire; Date of first sale 2013-01-29; Total offering amount $16,100,100.
- 2009-10-07: Federal exemption Rule 505; Types of securities offered OptionToAcquire; Date of first sale 2009-09-22; Total offering amount $1,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2023-05-08 | Rule 506(b) | Equity; Common Stock | 2023-04-10 | $35,897,425 | $35,897,425 | $0 | 40 |
|---|
| 2013-02-12 | Rule 506 | Debt; OptionToAcquire | 2013-01-29 | $16,100,100 | $2,000,100 | $14,100,000 | 25 |
|---|
| 2009-10-07 | Rule 505 | OptionToAcquire | 2009-09-22 | $1,000,000 | $0 | $1,000,000 | 2 |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
|---|